Jazz Pharmaceuticals (JAZZ) Treasury Shares (2012 - 2025)
Jazz Pharmaceuticals (JAZZ) posted quarterly Treasury Shares of $4.4 million for Q4 2025, up 9.25% year-over-year from $4.0 million in Q4 2024, and up 9.25% quarter-over-quarter from $4.0 million in Q4 2024.
Jazz Pharmaceuticals (JAZZ) Treasury Shares (2012 - 2025) Analysis & Trends
Jazz Pharmaceuticals' Treasury Shares history runs 14 years deep, the most recent figure standing at $4.4 million for Q4 2025.
- In Q4 2025, Treasury Shares rose 9.25% year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (up 9.25% YoY), while the FY2025 annual figure was $4.4 million, up 9.25% from the prior year.
- Treasury Shares for Q4 2025 stood at $4.4 million, up from $4.0 million in the prior quarter.
- The five-year high for Treasury Shares was $4.4 million in Q4 2025, with the low at $2.6 million in Q4 2021.
- The 5-year median for Treasury Shares is $3.6 million (2023), against an average of $3.6 million.
- The sharpest annual moves came in 2021 and 2025: Treasury Shares jumped 40.1% in 2021, then climbed 9.25% in 2025.
- Jazz Pharmaceuticals' Treasury Shares stood at $2.6 million in 2021, then rose by 21.97% to $3.2 million in 2022, then climbed by 11.03% to $3.6 million in 2023, then advanced by 13.19% to $4.0 million in 2024, then grew by 9.25% to $4.4 million in 2025.
- Business Quant data shows JAZZ's Treasury Shares at $4.4 million in Q4 2025, $4.0 million in Q4 2024, and $3.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.41 Mn |
| Dec 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Dec 31, 2023 | 3.56 Mn |
| Dec 31, 2023 | 3.56 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Dec 31, 2020 | 1.88 Mn |
| Dec 31, 2020 | 1.88 Mn |
| Dec 31, 2019 | 1.18 Mn |
| Dec 31, 2019 | 1.18 Mn |
| Dec 31, 2018 | 1.10 Mn |
| Dec 31, 2018 | 1.10 Mn |
| Dec 31, 2017 | 1.06 Mn |
| Dec 31, 2017 | 1.06 Mn |
| Dec 31, 2016 | 997,000.00 |
| Dec 31, 2016 | 997,000.00 |